Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Comparing individual and group intervention for psychological adjustment in people with multiple sclerosis: A feasibility randomised controlled trial.
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes.
Tetrahydrocannabinol
Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.
Neurotrophic factors and their effects in the treatment of multiple sclerosis.
MRI characteristics of neuromyelitis optica spectrum disorder: An international update.
Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.
What is the best treatment of drug-resistant trigeminal neuralgia in patients affected by multiple sclerosis? A literature analysis of surgical procedures.
Protective and therapeutic role for alphaB-crystallin in autoimmune demyelination.
Using the Multiple Sclerosis Impact Scale to Estimate Health State Utility Values: Mapping from the MSIS-29, Version 2, to the EQ-5D and the SF-6D.
Effectiveness of Energy-Conservation treatment in reducing fatigue in Multiple Sclerosis: a systematic review and meta-analysis.
Casting light on multiple sclerosis heterogeneity: the role of HLA-DRB1 on spinal cord pathology.
7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study.
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
The Role of CD8+ T Cells and Their Local Interaction with CD4+ T Cells in Myelin Oligodendrocyte Glycoprotein35-55-Induced Experimental Autoimmune Encephalomyelitis.
The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS).
The relationship between upper leg muscle strength and walking capacity in persons with multiple sclerosis.
Cutting Edge: TNF Receptor-Associated Factor 4 Restricts IL-17-Mediated Pathology and Signaling Processes.
Apolipoprotein E polymorphisms status in Iranian patients with multiple sclerosis.
T-cell trafficking in the central nervous system.
Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.
MRI measures should be a primary outcome endpoint in phase III randomised controlled trials in multiple sclerosis: Commentary.
[Magnetic reasonance spectroscopy-guided stereotactic biopsy for brain lesion].
Fingolimod Phosphate Attenuates Oligomeric Amyloid β-Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in Neurons.
The Puerto Rico study for the prevalence of Multiple Sclerosis.
Pages
« first
‹ previous
…
196
197
198
199
200
201
202
203
204
…
next ›
last »